Tyra Biosciences, Inc.
TYRA
$10.09
$0.020.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 318.94M | 341.44M | 360.13M | 373.80M | 382.46M |
| Total Receivables | 1.80M | 2.00M | 1.90M | 1.90M | 1.50M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.82M | 4.02M | 3.58M | 2.88M | 6.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 324.57M | 347.46M | 365.61M | 378.57M | 390.78M |
|
|
|||||
| Total Current Assets | 324.57M | 347.46M | 365.61M | 378.57M | 390.78M |
| Net Property, Plant & Equipment | 7.47M | 7.72M | 7.98M | 8.19M | 8.01M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.44M | 8.38M | 7.01M | 5.69M | 5.96M |
| Total Assets | 343.48M | 363.56M | 380.59M | 392.46M | 404.74M |
|
|
|||||
| Total Accounts Payable | 2.50M | 590.00K | 1.17M | 1.58M | 2.88M |
| Total Accrued Expenses | 11.32M | 13.59M | 10.81M | 8.42M | 5.47M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 426.00K | 412.00K | 398.00K | 383.00K | 370.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.25M | 14.59M | 12.37M | 10.38M | 8.72M |
|
|
|||||
| Total Current Liabilities | 14.25M | 14.59M | 12.37M | 10.38M | 8.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.70M | 5.81M | 5.92M | 6.02M | 6.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 3.00K | 11.00K | 20.00K | 29.00K |
| Total Liabilities | 19.94M | 20.41M | 18.30M | 16.42M | 14.86M |
|
|
|||||
| Common Stock & APIC | 602.30M | 593.69M | 586.28M | 577.95M | 572.91M |
| Retained Earnings | -279.46M | -251.31M | -225.74M | -201.72M | -183.02M |
| Treasury Stock & Other | 688.00K | 770.00K | 1.75M | -184.00K | -6.00K |
| Total Common Equity | 323.53M | 343.15M | 362.29M | 376.04M | 389.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 323.53M | 343.15M | 362.29M | 376.04M | 389.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 323.53M | 343.15M | 362.29M | 376.04M | 389.88M |
|
|
|||||